Please either sign in with your OSU user name (e.g. Smith.34323) before posting your replies.
- Please answer every question by responding with 1A), 2A), 1B), 2B), etc. You will not be graded on these.
- Do not forget to add a brief summary of the articles, as well as, something learned from them or how it will impact your practice.
- Please interact with at least one response in the replies. I have made the first reply for the first participant (However, you may reply to anyone’s response). This is considered the interaction between club members and is required as well.
Article A:
1A) What percentage of patients are expected to have possible EPS reactions from haloperidol (Stetson & Osser, 2022, p.172)?
a. 35% b. 25% c. 50% d. 90%
2A) What percentage of patients are expected to have possible EPS reactions from haloperidol and lorazepam (Stetson & Osser, 2022, p. 173)?
a. 20% b. 30% c. 80% d. 5%
Article B:
1B) True or False. Higher inflammation hampers response to antidepressants, and effective antidepressant treatment decreases inflammation (Benedetti et al., 2022, p.79).
Citations:
Article A)
Stetson, S. R., & Osser, D. N. (2022). Psychopharmacology of agitation in acute psychotic and manic episodes. Current Opinion in Psychiatry, 35(3), 171–176. https://doi.org/10.1097/yco.0000000000000787
In-text Citation: (Stetson & Osser, 2022)
Article B)
Benedetti, F., Zanardi, R., & Mazza, M. G. (2022). Antidepressant psychopharmacology: Is inflammation a future target? International Clinical Psychopharmacology, 37(3), 79–81. https://doi.org/10.1097/yic.0000000000000403
In-text Citation: (Benedetti et al., 2022)